Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery

C. Schmidt, R. Wenz, B. Nies and F. Moll, Antibiotic in vivo/in vitro release, histocompatibility and biodegradation of gentamycin implants on lactic acid polymers and copolymers, J. Control. Rel. 37 (1995) 83-94; DOI: 10.1016/0168-3659(95)00067-1.Search in Google Scholar

M.E.A. Mamun, H.A. Khan, I. Dewan and R.U. Jalil, In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants, Pak. J. Pharm. Sci. 22 (2009) 360-367.Search in Google Scholar

M. Ramchandani and D. Robinson, In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants, J. Control. Rel. 54 (1998) 167-175; DOI: 10.1016/s0168-3659(97)00113-2.10.1016/S0168-3659(97)00113-2Search in Google Scholar

P.Y. Wang, C.X. Song, H.F. Sun, H.L. Shi and R.W. Shi, A biodegradable long-term contraceptive implant, Eng. Med. Biol. Soc. 6 (1998) 2901-2904; DOI: 10.1109/IEMS.1998.746093.Search in Google Scholar

http://www.surgistrategies.com/hotnews/baxter-agreement-with-innocall-implant.htmlSearch in Google Scholar

C. Guse, S. Koennings, F. Kreye, F. Siepmann, A. Goepferich and J. Siepmann, Drug release from lipid-based implants: Elucidation of the underlying mass transport mechanisms, Int. J. Pharm. 314 (2006) 137-144; DOI: 10.1016/j.i.jpharm.2005.08.030.Search in Google Scholar

J.C. Shah and S. Allababidi, Glyceryl Monostearate Based Biodegradable Implants for Site Specific Delivery of Drugs, U.S. Pat. 5,891,456, 6 Apr 1999; ref. Chem. Abstr. 130 (1999) 271997f.Search in Google Scholar

United States Pharmacopoeia 30, National Formulary 25, United State Pharmacopeial Convection, Rockville 2007, pp. 1759-1760.Search in Google Scholar

S. Allababidi and J. Shah, Kinetic and mechanism of release from glyceryl monostearate based implants: Evaluation of release in a gel simulating in vivo implantations, J. Pharm. Sci. 87 (1998) 169-172; DOI: 10.1021/js9703986.10.1021/js9703986Search in Google Scholar

ICH Harmonised Tripartite Guideline, Stability Testing of New Drug Substances and Products, Q1A (R2), Current Step 4 version, 6 February 2003.Search in Google Scholar

P. Costa and J.M.S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133.10.1016/S0928-0987(01)00095-1Search in Google Scholar